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A C C E P T E D M A N U S C R I P T Introduction
Cardiac hypertrophy is a maladaptive reaction in response to pressure or volume stress. The main pathological changes in cardiac hypertrophy present as changes with many aspects, including myocardial interstitial cell hypertrophy, myocardial interstitial cell proliferation, and extracellular matrix increase of myocardial cells, thus leading to myocardial remodeling [1] . Fibrosis constitutes a major hypertrophic pathological development in addition to myocardial cell hypertrophy. [11, 12] 
. In the study by Zhang et al, DKK3 was reported to act as a cardioprotective regulator of pressure-induced cardiac hypertrophy via the regulation of ASK1-JNK/p38 signaling. Moreover, neurohumoral factors such as the renin-angiotensin system (RAS), aldosterone, catecholamine and endothelin, are common causes of cardiac hypertrophy. Among these factors, the RAS is the main and
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most influential pathogenic factor. Several studies have indicated that activation of the RAS contributes to cardiac remodeling [5] [6] [7] . Angiotensin II (AngII) has a central role in mediating most of the effects of the RAS and is a key trigger of heart hypertrophy and fibrosis [8] . Angiotensin-converting enzyme (ACE) 2 is an enzyme that hydrolyzes AngII into Ang-(1-7) [9] . Ang-(1-7) also has a broad range of effects on cardiovascular tissues, such as improving vascular endothelial function, decreasing matrix metalloproteinase 9 (MMP9) expression and reducing neutrophil and macrophage infiltration [10, 11] . Adisintegrin and metalloproteinase (ADAM) 17, also known as TNFα-converting enzyme (TACE), is a member of the superfamily of Zn-dependent metalloproteases; it is a type I transmembrane protein that plays a key role in regulating the proteolytic release of some cytokines, chemokines, growth factors and their receptors from cellular membranes [12] . ADAM17 was recently shown to cleave ACE2, leading to ACE2 down-regulation [13] . Aside from aortic banding, AngII infusion is another classical method of constructing cardiac hypertrophy mouse models; this method was particularly suitable for the present study due to the direct use of AngII. However, the mechanism by which DKK3 contributes to AngII-induced cardiac hypertrophy remains to be elucidated. Currently, no studies ha ve examined the relationships between DKK3, ADAM17, and ACE2. Therefore, we proposed the hypothesis that DKK3 inhibits AngII-induced cardiac hypertrophy and fibrosis by decreasing ADAM17 activity and increasing ACE2 expression. Because DKK3 regulates the glycogen synthase kinase-3β (GSK-3β)/β-catenin pathway in many cell types and diseases [14] [15] [16] , we determined whether DKK3 controls
ADAM17/ACE2 via this pathway.
The present study was designed (i) to determine whether DKK3 expression changes in an AngII-perfused animal model, (ii) to determine whether DKK3 overexpression attenuates cardiac hypertrophy and fibrosis, (iii) and if so, to determine whether this protective response is related to the regulation of the ADAM17/ACE2 pathway, (iv) and whether the ADAM17/ACE2 pathway is modulated by the GSK-3β/β-catenin pathway.
Methods
Primary cultures of cardiac fibroblasts
Primary cardiac fibroblasts (CFs) were prepared from the hearts of 1-to 3-day-old neonatal C57BL/6 mice, as previously described [12] . Briefly, after sacrifice by decapitation, the sternum of the neonatal mice was longitudinally incised to expose the heart. Then, the heart was isolated and cut into pieces in DMEM. The pieces were digested with collagenase type II for 3 h at 37°C. Then, the liquid supernatant was centrifuged, and cells were cultured in DMEM containing 10% fetal bovine serum (FBS) (Gibco, California, USA) and penicillin-streptomycin (100 U/ml penicillin, 100 g/ml streptomycin) (Gibco, California, USA) at 37°C with 5% CO 2 . Two hours later, the culture medium was replaced to remove all cells except the CFs. The cells were subcultured in subsequent experiments.
Cell transduction and drug administration
The DKK3-overexpressing adenovirus was purchased from Abm (Cat: 190468A, Canada) and amplified by the Chinese National Human Genome Center, Beijing. CFs
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were pretreated with DKK3 overexpression adenovirus or adenovirus vehicle (MOI=100) for 24 h before AngII (1 μg/ml) stimulation and were cultured for an additional 48 h to evaluate the effect of DKK3 overexpression [17] . The CFs were divided into six groups as follows: 
Animal model
Based on the results of the preliminary in vitro experiment, the AngII group presented similar results as the AD+AngII group, and the results observed in the NC group were similar to the AD group. We removed the AngII and NC groups to conduct our in vivo experiment with fewer animals. Sixty male wild-type C57BL/6 mice (10-12 weeks of age) were chronically infused with saline or AngII at a rate of 1000 ng/kg/min using osmotic mini-pumps (Alzet, Cupertino, CA) for 28 days as described previously [18] . The DKK3-overexpressing adenovirus or vehicle (2×10 9 pfu) [19] was administered by a caudal vein injection 3 days before the operation. On day 15, mice were injected again. Mice were divided into four groups randomly and 
Quantitative real-time RT-PCR
Total RNA was extracted from the left ventricle of mice or CFs using TRIzol reagent (Invitrogen, CA). A real-time PCR thermocycler (IQ5 real-time PCR cycler; Bio-Rad) was utilized to perform the quantitative real-time PCR. PCR was performed at 95°C for 30 s, followed by 40 cycles of 95°C for 5 s and 56°C for 10 s. The transcript GAPDH content was quantified as an internal control. The results were calculated using the 2 △△CT method.
Western blot (WB) analyses
Total proteins and nuclear proteins were extracted from CFs or mouse cardiac tissues, and equal amounts of protein were electrophoretically separated and then 
Cell proliferation assay (EdU)
Cell proliferation was determined with an EdU incorporation assay, as previously described [20] . Briefly, CFs were seeded into slides and administered different drugs or adenovirus the day before staining. CFs were supplemented with 1% FBS and 20 μΜ 5-ethynyl-2'-deoxyuridine (EDU) (RiboBio, Guangzhou, China). Cells were fixed with 4% paraformaldehyde for 20 min and then permeabilized with 0.1% Triton X-100 for 30 min at room temperature. Then, 50 μl of 2 mg/ml glycine were added to each well to neutralize the PFA. The cells were exposed to 100 μl of Apollo-Fluor 
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of EDU-positive cells were determined, and three independent experiments were performed.
Immunofluorescence
CFs were briefly washed with cold PBS 3 times and fixed with 4% paraformaldehyde for 30 min. Then, the CFs were washed thrice, blocked in 5% goat serum albumin for 30 min, and permeabilized using Triton X-100. Cells were incubated with a primary rabbit anti-active-β-catenin antibody overnight at 4°C, followed by an incubation with the secondary antibody (ZSGB-Bio, Peking, China).
Nuclei were stained with DAPI for 5 min at room temperature, and immunofluorescence was analyzed under a florescence microscope.
ELISA
The level of DKK3 in mouse plasma was measured using ELISA kits (kit 50247, SinoBiological Inc., Wuhan, China), according to the manufacturer's instructions. The levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in mouse plasma were measured using ELISA kits (eBioscience, San Diego, USA). The level of
Ang-(1-7) in mouse plasma was measured using an ELISA kit (J&L Biological,
Shanghai, China). The experiment was repeated thrice, and the average number was adopted.
Detection of mice echocardiography and pathological samples
Echocardiographic imaging was performed post-operatively. The following parameters were tested: left ventricular ejection fraction (LVEF), ratio of early to late mitral inflow velocity (E/A), fractional shortening (FS), and the thickness of the left
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. Systolic blood pressure was measured using the tail-cuff method at 3 and 31 d as previously described [18] . Before the mice were sacrificed, body weights were recorded and their tibias were measured. Next, mice hearts were dissected and weighed to calculate the ratio to the body weight.
Indexes were calculated including heart weight (HW)/body weight (BW) and HW/tibial length (TL). Mouse hearts were then photographed to observe their morphology.
Histopathology and immunohistochemistry
Mouse hearts were dissected and fixed in 4% formalin. Heart sections were 
Statistical analysis
All data are expressed as the mean±standard deviations (SD). Statistical analysis was performed with either Student's t-test or one-way ANOVA as appropriate. P values<0.05 were considered statistically significant.
Results
DKK3 overexpression alleviates AngII-induced cardiac dysfunction and
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A mouse model of cardiac hypertrophy was constructed to determine whether DKK3 overexpression exerted a protective effect on myocardial hypertrophy. Mice were chronically infused with AngII at a rate of 1,000 ng/kg/min using osmotic mini-pumps for 28 days to generate cardiac hypertrophy [18] . In our experiment, mice in the treatment group were injected with the DKK3-overexpressing adenovirus, and other groups were treated as described in the Methods. First, immunoblot and ELISA analyses confirmed that the injection of the DKK3-overexpressing adenovirus elevated the DKK3 level in both the cardiac tissue and serum ( Fig. 1a-1 ,1a-2 and 1c).
In vitro, DKK3 adenovirus transduction also elevated DKK3 expression (Fig. 1b-1 S1a) . We found that cardiac hypertrophy was successfully alleviated in the DKK3 overexpression group compared to that in the control group.
Representative images of each group are shown in Fig. 1d . The inhibition of cardiac hypertrophy was also evidenced by the decreased ratios of HW/BW and HW/TL. The value of BW was close to that of TL, and there were no significant differences between them; thus, we showed only HW/TL in Fig. 1e . The cross-sectional area of cardiomyocytes examined with wheat germ agglutinin (WGA) staining revealed an alleviation of AngII-induced cardiac hypertrophy in the DKK3-overexpressing group (Fig. 2a and 2b) . RT-PCR showed that the hypertrophic markers atrial natriuretic peptide (ANP) and beta-myosin heavy chain (β-MHC) were markedly decreased in
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AngII-treated DKK3-overexpressing mice compared to those in AngII-treated adenovirus-null mice (Fig. 2c) . AD:119.7±13.5/88.7±5.7 mmHg), but no significant differences were detected between the OV+AngII and AD+AngII groups or the OV and AD groups.
Overexpression of DKK3 inhibits AngII-induced cardiac fibrosis
To further determine whether DKK3 overexpression inhibits AngII-induced cardiac fibrosis, a histological examination was performed on heart sections.
Masson's trichrome staining revealed a significant decrease in interstitial and perivascular fibrosis in DKK3-injected and AngII-infused mice compared with those in vehicle-injected mice ( Fig. 3a-3b ). Immunohistochemistry staining confirmed that the levels of the fibrotic markers collagen I and collagen III were significantly down-regulated in DKK3-treated mice compared with those in vehicle-treated animals after the AngII infusion ( Fig. 3a and 3c ). The levels of collagen I and
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T collagen III were detected by WB, which were similar to those detected by immunohistochemical staining (Fig. 3d-3e (Fig. S1b-S1c ).
DKK3 overexpression inhibits the inflammatory reaction caused by AngII perfusion
Cardiac hypertrophy is a type of inflammatory disease. WB showed that expression of the inflammatory cytokine IL-6 was decreased in the DKK3 overexpression group in vitro (Fig. 4a-1 and 4a-2) . Based on the results of the in vivo histological analysis, the levels of IL-6, T cells and macrophage markers CD45 and CD68 were reduced in the DKK3 group compared with those in the vehicle group (Fig. 4b1-4b4) . Moreover, ELISAs revealed a dramatic decrease in the expression of proinflammatory cytokines, including IL-1β and TNF-α, in DKK3-treated mice compared with that in controls after the AngII infusion ( Fig. 4c-4d ).
DKK3 overexpression reduces the expression of matrix metalloproteinases (MMPs) in CFs
Fibroblasts secrete MMPs, which are involved in matrix degradation. The accumulated amount and increasing activity of MMPs represents the severity of organ fibrosis. WB was used to evaluate the content of MMPs in vitro. MMP2 and MMP9 expression was increased in the AD+AngII and AD groups, but decreased in the ACCEPTED MANUSCRIPT
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OV+AngII group (Fig. 4e-1 and 4e-2 ).
DKK3 overexpression inhibits proliferation and promotes apoptosis in CFs
As most collagens are produced by CFs, CF proliferation seems to be a crucial event in cardiac hypertrophy pathophysiology. According to the results of the EdU assays, DKK3 overexpression inhibited CF proliferation in the OV+AngII group (Fig.   5a-1 and 5a-2) . Meanwhile, the apoptosis markers bax and bcl-2 were detected by WB and a higher ratio was detected in the OV+AngII group, indicating that apoptosis increased upon DKK3 overexpression (Fig. 5b ).
DKK3 overexpression reduces the level of phosphorylated ADAM17, thus increasing the ACE2 content and Ang-(1-7) concentration
Immunoblots were performed using total proteins from CFs to examine the relationships between DKK3, ADAM17 and ACE2. DKK3 inhibited ADAM17
phosphorylation, but the total ADAM17 level exhibited little change (Fig. 5c) .
Meanwhile, the AngII-induced decrease in ACE2 expression was restored by DKK3 (Fig. 5e) . Based on the results obtained from the in vitro assessment, ADAM17 phosphorylation decreased and ACE2 expression increased in the OV+AngII group compared to those in the AD+AngII group ( Fig. 5d and 5f ). We also performed immunohistochemistry to detect ACE2 expression and observed increased ACE2 expression in the OV+AngII group compared to that in the AD+AngII group (Fig.   5g-1 and 5g-2 (Fig. s2c) . (Fig. S1d-1e ).
A C C E P T E D M A N U S C R I P T difference in plasma Ang-(1-7) concentration among the other three groups
The anti-hypertrophic and anti-fibrotic effects of DKK3 overexpression are linked to its inhibition of the GSK-3β/β-catenin pathway
We examined the levels of the GSK-3β/β-catenin pathway in vitro to further investigate the mechanism by which DKK3 regulates AngII-induced ECM deposition.
DKK3 overexpression reduced the p-GSK-3β and active β-catenin levels ( Fig. 6b and   6d ). Immunofluorescence staining revealed only a very weak β-catenin signal in the nuclei of CFs in the OV+AngII group, but the signal was markedly strengthened in the nuclei of CFs treated with AngII alone (Fig. 6a) . Based on the immunoblot analysis, p-GSK-3β was also reduced by DKK3 in vivo (Fig. 6c) . In the siRNA transfection experiment, DKK3 silencing increased the levels of activated β-catenin and phosphorylated GSK-3β in the presence of AngII compared to NC-siRNA transfection ( Fig. S1f-S1g) . Thus, DKK3 influenced ADAM17/AC E2 activity to reduce the detrimental effects of AngII, potentially by suppressing GSK-3β phosphorylation and β-catenin accumulation in the nucleus.
DKK3 overexpression protected against cardiac hypertrophy by regulating the TGF-β1/Smad3 pathway
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As is known, the TGF-β1 and Smad pathway promotes collagen generation in many
tissues and diseases [21] [22] [23] 
Discussion
In this study, low levels of DKK3 expression were observed in the hypertrophic myocardium, and DKK3 overexpression reversed the effects of AngII on cardiac hypertrophy and fibrosis. During cardiac remodeling, the most apparent change is enlargement of the heart, which is due to hypertrophy and fibrosis. Based on our observations of the mouse model of AngII-induced cardiac remodeling, DKK3 overexpression ameliorated cardiac hypertrophy by attenuating cardiomyocyte enlargement and the increase in HW/BW and HW/TL and by decreasing the expression of fetal genes, including ANF and β-MHC (Fig.1e, 2a , 2b and 2c), along with fibrosis, during remodeling by decreasing the collagen synthesis ( Fig. 3a and   3d ).
Cardiac hypertrophy and fibrosis are induced by many factors, such as mechanical pressure overload or the humoral factors endothelin and AngII. AngII, the most important constituent of the renin-angiotensin-aldosterone system (RAAS), exerts direct effects on myocardial cells and CFs, causing cell growth, hypertrophy,
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and extracellular matrix accumulation [24, 25] . Numerous interactive signaling pathways transduce the AngII-induced pro-fibrosis and pro-hypertrophy signals to the nucleus, leading to the reprogramming of gene expression. Methods that transform the excessively detrimental AngII into a protective factor must benefit the injured heart.
The ACE2/Ang 1-7/Mas receptor axis is a physiological antagonist of the RAS, where ACE2 cleaves AngII and generates Ang-(1-7) [9] . Ang-(1-7) is a factor that protects the cardiovascular system and has a role in improving vascular endothelial function by decreasing MMP-9 expression and reducing neutrophil and macrophage infiltration [10, 11] . (Fig. S2c) . Therefore, we proposed the hypothesis that DKK3 overexpression may increase ACE2 expression and thus affect the cardiac impairment caused by AngII. Immunoblots of cell and tissue lysates were performed to verify this hypothesis. The perfusion of AngII in mice and the addition of AngII to the CFs decreased ACE2 expression, which was restored by DKK3 overexpression (Fig. 5e and 5f ). In contrast, DKK3 silencing resulted in decreased of ACE2 expression (Fig. S1e) . According to the immunohistochemical staining, DKK3 overexpression also increases ACE2
expression in the heart tissue ( Fig. 5g-1, 5g-2) . We examined the pathway upstream of ACE2 to identify the intracellular mechanism by which DKK3 influenced ACE2.
AngII was recently shown to induce ACE2 shedding by promoting ADAM17 activity through a positive feedback mechanism [27] . Therefore, we examined the relationship between DKK3 and ADAM17. In our study, the overexpression of DKK3 in CFs had no effect on the total ADAM17 level, but influenced its phosphorylation state.
P-ADAM17 levels decreased in the OV+AngII and OV groups ( Fig. 5c and 5d ) and increased in the DKK3-siRNA group (Fig. S1d) .
In addition to the ADAM17/ACE2 pathway, DKK3 also inhibits the GSK-3β/β-catenin signaling pathway. GSK-3β, an anti-hypertrophic kinase, is inactivated when it is phosphorylated following AKT activation [28] . Consequently, GSK-3β is recruited to the Frizzled receptor, thereby inhibiting GSK-3β and reducing its availability for binding to β-catenin. β-catenin is an adhesion-associated protein whose phosphorylation causes its degradation in the cytoplasm. As a consequence, accumulated β-catenin in the cytoplasm is shuttled into the nucleus, which augments the expression of pro-hypertrophic and pro-fibrosis genes [29, 30] . The signaling function of β-catenin is primarily regulated by alterations in its stability. Wnt signaling induces stabilization of cytoplasmic β-catenin [31] . Here, DKK3
overexpression resulted in the inactivating phosphorylation of GSK-3β (Fig. 6b-6c ).
DKK3 is a secreted protein in the dickkopf family and acts as an inhibitor of Wnt/β-catenin signal depending on the cellular context [32] . Hirschy A et al. reported that mice expressing a non-degradable form of β-catenin developed dilated
cardiomyopathy and died after 5 months of age [33] . In our study, the accumulation of β-catenin in the nucleus was suppressed in the DKK3 overexpression group, thus alleviating AngII-induced hypertrophy (Fig. 6a and 6d) . Meanwhile, opposite results were obtained in the siRNA experiment (Fig. S1f-1g) . In this study, the excess accumulation of ECM components, including collagen I and collagen III, decreased in the DKK3 overexpression group and increased in the DKK3-siRNA group, indicating that DKK3 suppressed AngII-induced cardiac fibrosis (Fig. 3a-3e , S1b-S1c).
Moreover, DKK3 overexpression improved cardiac function, as indicated by the LVEF, LVPWD, E/A and FS values, and blocked the changes in cardiac structure in AngII-infused mice (Fig. 2d-2h ).
Due to the close relationship between the TGF-β1/Smad3 pathway and collagen
synthesis, we examined these two molecules both in the DKK3 overexpression experiment and siRNA silencing experiment. Consistent with previous reports [21] [22] [23] , increased collagen expression accompanied the increase in TGF-β1 and Smad3
expression. Moreover, DKK3 overexpression reduced this abnormity in TGF-β1 and
Smad3 expression caused by AngII, whereas DKK3-siRNA aggravated it (Fig. S1h-S1i, 
S2a-2b).
The mechanism by which DKK3 decreases the synthesis of ECM became the next focus of this study. Fibroblasts are known to secrete ECM, such as collagen I and III, which contribute to the development of cardiac remodeling and fibrosis. Similarly, MMPs, which are involved in matrix degradation, are also secreted by fibroblasts.
The accumulated amount and increasing activity of MMPs indicates the severity of
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organ fibrosis [34] . In the present study, MMP2 and MMP9 activity increased in AngII-treated fibroblasts, which was reversed by DKK3 overexpression (Fig. 4e-1 and 4e-2). This finding suggests that the protective role of DKK3 might be partially to regulate the MMP balance.
Inflammatory signaling in cardiomyocytes has recently been found to occur as part of the pathophysiologic process in response to cardiac hypertrophy, fibrosis, and dysfunction in heart disease. IL-1β, TNF-α and IL-6 have been shown to exert a causative effect on the development of cardiac hypertrophy and dysfunction [35] [36] [37] .
In our study, fibroblasts treated with AngII exhibited increased expression of IL-1β, TNF-α and IL-6, which was suppressed by DKK3 overexpression (from Fig. 4a-1 to   4d ). This result was consistent with a report that IL-6 genetic deletion ameliorated angiotensin-II-induced cardiac hypertrophy and fibrosis [38] . In addition to IL-6, macrophages and T cells also participate in the development of cardiomyopathy [39] .
An experiment in which macrophages were non-selectively depleted at an early stage reduced the cardiac inflammatory response and improved cardiac function [40] .
Immunohistochemistry in our experiment showed a decline in CD45 and CD68
contents when cells were treated with DKK3 compared to those in cells treated w ith AngII ( Fig. 4b-1, 4b-3 and 4b-4 ).
The apoptosis of cardiomyocytes, which react to different pathogeneses, is an important part of cardiac hypertrophy. Inflammation and oxidative stress are directly related to apoptosis in hypertrophic hearts of diabetic patients and animals [41] [42] [43] .
We performed EdU staining to evaluate the proliferation of CFs and WB of bcl-2
family proteins to detect apoptosis of CFs. Bcl-2 proteins are members of the Bcl family that can prevent cell death and increase cell proliferation and growth. In contrast, bax is a protein that can promote cell death [44] . In this study, the ratio of bax/bcl-2 increased in the DKK3 overexpression group compared to that in the AngII-treated group (Fig. 5b) . Meanwhile, the percentage of EdU-positive cells in the DKK3 overexpression group decreased compared to that in the AngII-treated group (Fig. 5a-1 and 5a-2) .
Our study has a few limitations. For example, the precise relationship between the ADAM17/ACE2 pathway and the GSK-3β/β-catenin signaling pathway requires further study. Overexpression of components of the GSK-3β/β-catenin pathway should verify whether DKK3 loses its inhibitory effect on ADAM17. Therefore, our future studies will perform this overexpression experiment both in vitro and in vivo.
Additionally, the use of transgenic animals and the knockdown of the DKK3 gene would provide better data to explain the effect of DKK3. In conclusion, the current study indicates that DKK3 overexpression effectively reduces cardiac hypertrophy and fibrosis and improves cardiac function in an
AngII-perfused mouse model. These cardioprotective properties appear to be due to direct influences on the ADAM17/ACE2 pathway that may be achieved via the inhibition of the GSK-3β/β-catenin signaling pathway. Importantly, DKK3 attenuates AngII-induced MMP2 and MMP9 expression and inhibits collagen synthesis in vitro.
Furthermore, DKK3 overexpression alleviated the inflammatory reaction and proliferation of CFs caused by AngII. Above all, these results confirmed for the first time that DKK3 exerts cardiac protective effects against cardiac remodeling.
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